Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Bullish on GitLab Ahead of FourthQuarter Earnings Release

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
CRWD stock news
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

GitLab Inc. (NASDAQ: GTLB) is gearing up to unveil its fourth-quarter earnings on March 4, 2024. Analysts are predicting a quarterly profit of 8 cents per share, a notable improvement from a loss of 3 cents per share a year ago, with expected revenue of $158.21 million compared to $122.91 million in the previous year.

_____

Several analysts have made adjustments to their forecasts for GitLab:

– Truist Securities analyst Barry Jonas reaffirmed a Buy rating and boosted the price target to $80 on Feb. 20, 2024.
– DA Davidson analyst Gil Luria maintained a Neutral rating and raised the price target to $75 on Feb. 5, 2024.
– Mizuho analyst Gregg Moskowitz upgraded the stock from Neutral to Buy with a price target of $73 on Jan. 8, 2024.
– Goldman Sachs analyst Kash Rangan kept a Buy rating and increased the price target to $80 on Dec. 6, 2023.

_____

Furthermore, GitLab is expected to see substantial growth in both earnings and revenue, with an estimated annual growth rate of 64.6% and 23%, respectively. The average price target for GitLab stands at $72.33, suggesting a potential upside of 7.36% from the current price. Overall, analysts have bestowed GitLab with a consensus rating of Moderate Buy following recent assessments.

GTLB Stock Shows Positive Performance on March 4, 2024: Analysis and Trends

On March 4, 2024, GTLB stock had a relatively positive performance, trading near the top of its 52-week range and above its 200-day simple moving average. The stock opened at $74.72, which was $1.41 higher than its previous close. Throughout the trading day, the price of GTLB shares increased by $0.06, representing a 0.08% rise.

Investors may be attracted to GTLB for a variety of reasons, such as strong financial performance, positive industry trends, or potential growth opportunities. It is important for investors to conduct their own research and analysis before making any investment decisions.

GTLB Stock Reports Mixed Performances in Financial Results for Past Year and Third Quarter 2024

On March 4, 2024, GTLB stock experienced mixed performances as the company released its financial results for the past year and the third quarter. According to data from CNN Money, GTLB reported a total revenue of $424.34 million for the past year, representing a 67.95% increase compared to the previous year. However, total revenue for the third quarter stood at $149.67 million, showing a 7.23% increase from the previous quarter.

Despite the increase in total revenue, GTLB reported a net income of -$172.31 million for the past year, which is a decrease of 11.07% compared to the previous year. The net income for the third quarter was even lower at -$285.16 million, marking a significant decrease of 469.4% from the previous quarter.

Earnings per share (EPS) also saw a decline for GTLB, with an EPS of -$1.16 for the past year, down by 9.93% from the previous year. The EPS for the third quarter was even lower at -$1.84, showing a substantial decrease of 463.9% from the previous quarter.

Overall, GTLB stock performances on March 4, 2024, were mixed, with an increase in total revenue but a decrease in net income and earnings per share. Investors may need to closely monitor the company’s financial performance and future outlook to make informed decisions regarding their investments in GTLB.

Tags: GTLB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Capitalistic

Cantor Fitzgerald Analyst Reiterates Overweight Rating on 89bio with 29 Price Target

Title Astrophysics Breakthrough Discovery of New Celestial Body Challenges Current Understanding of the Universe

Healthcare-and-IT

Amesite Partners with PACE to Revolutionize Healthcare Continuing Education

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com